Haleon plc (HLN)
NYSE: HLN · Real-Time Price · USD
9.17
+0.21 (2.34%)
May 18, 2026, 4:00 PM EDT - Market closed
Haleon Market Cap
Haleon has a market cap or net worth of $40 billion as of May 19, 2026. Its market cap has decreased by -16.23% in one year.
Market Cap
40.00B
Enterprise Value
49.84B
1-Year Change
-16.23%
Ranking
Category
Stock Price
$9.17
Market Cap Chart
Since July 18, 2022, Haleon's market cap has increased from $34.14B to $40.00B, an increase of 17.16%. That is a compound annual growth rate of 4.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 39.33B | -12.46% |
| Dec 31, 2025 | 44.93B | 5.03% |
| Dec 31, 2024 | 42.77B | 13.06% |
| Dec 29, 2023 | 37.83B | 3.87% |
| Dec 30, 2022 | 36.42B | 6.67% |
| Jul 18, 2022 | 34.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Takeda Pharmaceutical Company | 52.54B |
| Teva Pharmaceutical Industries | 39.93B |
| Zoetis | 31.12B |
| United Therapeutics | 24.13B |
| Viatris | 19.19B |
| Neurocrine Biosciences | 15.93B |
| Regencell Bioscience Holdings | 14.13B |
| Dr. Reddy's Laboratories | 11.60B |